
1655: Illegal Chants
mRNA Cancer Vaccine Trials, Melanoma Treatment
NHS patients in the UK have begun trials for a personalized mRNA vaccine designed to treat melanoma. The experimental treatment, which identifies proteins unique to an individual's tumor, is used in combination with other drugs and has shown a 49% reduction in the risk of death or recurrence over three years in early stages.










